Phase II of a clinical trial is recruiting mesothelioma patients to test the effectiveness of two immunotherapy medications in combination.
Each year on September 26th, the medical community observes Mesothelioma Awareness Day. This year, Mesothelioma Hub remembers Inez St. John.
Making Immunotherapy Mainstream An immunotherapy procedure showing promise in the treatment of mesothelioma may soon be covered under Medicare. In August, the Centers for Medicare & Medicaid Services (CMS) approved the use of Chimeric Antigen Receptor, (CAR T-cell), therapy in patients with two specific cancers: non-Hodgkin lymphoma and B-cell precursor acute lymphoblastic leukemia. CAR T-cell … Continued
The results of a recent Phase 3 clinical trial have led to a disappointing setback for the mesothelioma community: a highly-touted immunotherapy drug has failed to stop the progression of the disease. Researchers involved in the LUME-Meso study, which combined Ofev (nintedanib) with first-line chemotherapy drugs, say the treatment failed to slow the progression of … Continued
The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs. New Technology Disrupts Cancer Cell Division Patients have a new weapon in the fight against pleural mesothelioma: Novocure’s TTF-100L™ System. Last month, the Food and Drug Administration (FDA) approved the global oncology company’s “Tumor Treating Fields” (TTF) technology for … Continued
An new Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy to attack pleural mesothelioma tumors shows promise for cancer patients.
State and Federal Lawmakers Push to Ban Asbestos in 2019 Legislators in New Jersey have unanimously voted to ban asbestos. A bill that prohibits the sale and distribution of asbestos-containing products passed both the Senate and General Assembly on March 25, 2019, and is now awaiting the governor’s signature. Once the law goes into effect, … Continued
Maggie Rieber and her mother, Robin Roberts, sat at a round table in the middle of a large conference room. On the table in front of her was a small, lined, yellow notepad. Every few minutes, Maggie nodded her head and added another detail to a growing list on the page. “This conference is great,” … Continued